Huminig, Ayisha .
HRN: 27-31-84 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2025
CEFUROXIME 750MG (VIAL)
11/25/2025
12/02/2025
IV
430 Mg
Q 8 Hours
UTI
Checking Final Appropriateness
11/27/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/27/2025
12/02/2025
ORAL
3.5ml
BID
URTI
Checking Final Appropriateness